Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 24, 2009

Kyoto Buys Fluidigm’s Technology to Research Stem Cell Reprogramming

  • Kyoto University’s Center for iPS Cell Research and Application (CiRA) purchased Fluidigm’s BioMark™ System to use in researching stem cell reprogramming.

    CiRA is using the microfluidic properties of BioMark’s integrated fluidic circuits to analyze selected genes in induced pluripotent stem (iPS) cells. The institute is also using the system to quantify copies of specific genes transferred into a cell to generate iPS cells.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »